Mesothelioma Applied Research Foundation Advocacy Pays Off in Government Awarded Grants
Monday, December 14, 2009 The Mesothelioma Applied Research Foundation (MARF) announced today that several million dollars in grants has been awarded by the DoD for three mesothelioma research projects. The awards are in response to a 2007 directive from the Senate Defense Appropriations Subcommittee for DoD to fund mesothelioma research through its Peer Reviewed Medical Research Program (PRMP).
The funded projects include:
- Harvey Pass, M.D., co-author of “100 Questions and Answers About Mesothelioma,” and Margaret E. Huflejt, PhD. will investigate new markers for early detection of mesothelioma, and identify new therapeutic targets.
- Lee Krug, M.D. will lead a multi-site clinical trial of a new therapy based on the WT-1 vaccine.
MARF has been a staunch advocate for mesothelioma victims that Congress direct the DoD to include funding to promote research on diseases related to military service. Asbestos exposure, the primary known cause for mesothelioma, is a known hazard for sailors working on Navy ships. MARF estimates that one third of those who currently die from mesothelioma were exposed to asbestos on U.S Navy ships.
MARF representatives have met with elected government officials at the Foundation’s annual Washington, D.C. Advocacy Day, testified at hearings, distributed educational materials, and have sent countless emails and letters.
MARF is a national non-profit organization dedicated to finding a cure for mesothelioma “by funding mesothelioma research, educating and supporting mesothelioma patients, and advocating for a national commitment to end the mesothelioma tragedy.”
[Via-mesotheliomahelp.net]
Related posts:
